Viewing Study NCT05601232


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-01-02 @ 1:25 AM
Study NCT ID: NCT05601232
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-09
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
Sponsor: Stella Pharma Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module